drugset

drugset / Trial / NCT04255589

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495

NCT04255589 ↗

Phase 3 Completed 242 enrolled Chong Kun Dang Pharmaceutical

RandomizedParallel-groupDouble-blindTreatment

Summary

To Evaluate the Efficacy and Safety of CKD-495

Timeline

Start: 2020-01-06
Primary completion: 2021-05-20
Completion: 2021-05-20

Publications

Seo SY, Lee ST, Kim SK, Chun HJ, Song GA, Lee DH, Kim JJ, Kim JI, Lee YC, Kim TN, Jee SR, Park SY, Kim JG, Park JJ, Kim SG, Park JM, Park JH, Park SJ, Lee OY. Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial. Medicine (Baltimore). 2023 Dec 8;102(49):e35926. doi: 10.1097/MD.0000000000035926.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Artemisiae argyi folium	Unknown	60 mg	—
Subject	CKD-495	Unknown	75 mg	—

Indications